NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 58 filers reported holding NIVALIS THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $67,000 | -72.5% | 30,000 | 0.0% | 0.02% | -66.2% |
| Q3 2016 | $244,000 | +76.8% | 30,000 | 0.0% | 0.07% | +57.4% |
| Q2 2016 | $138,000 | +10.4% | 30,000 | 0.0% | 0.05% | +4.4% |
| Q1 2016 | $125,000 | -46.1% | 30,000 | 0.0% | 0.04% | -41.6% |
| Q4 2015 | $232,000 | -40.4% | 30,000 | 0.0% | 0.08% | -36.4% |
| Q3 2015 | $389,000 | -14.5% | 30,000 | 0.0% | 0.12% | -8.3% |
| Q2 2015 | $455,000 | – | 30,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|